Buhle Moyo

Rice University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index511citations13works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(8), CRISPR and Genetic Engineering(6), Hepatitis B Virus Studies(4), Viral Infectious Diseases and Gene Expression in Insects(3), Viral gastroenteritis research and epidemiology(2)

Publications13 total

Engineering adeno-associated viral vectors for CRISPR/Cas based in vivo therapeutic genome editing
Biomaterials·2025· 7 citedOpen Access
Haplotype rather than single causal variants effects contribute to regulatory gene expression associations in human myeloid cells
2025Open Access
Covalently linked adenovirus-AAV complexes as a novel platform technology for gene therapy
2024· 1 citedOpen Access
Encapsulation of AAVs into protein vault nanoparticles as a novel solution to gene therapy’s neutralizing antibody problem
2023· 2 citedOpen Access
Site-Specific Post-translational Surface Modification of Adeno-Associated Virus Vectors Using Leucine Zippers
ACS Synthetic Biology·2020· 13 citedOpen Access
Engineered materials for in vivo delivery of genome-editing machinery
Nature Reviews Materials·2019· 197 citedOpen Access
ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells
Scientific Reports·2017· 62 citedOpen Access
Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus
Virus Research·2017· 67 cited
Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus
Molecular Therapy·2016· 39 citedOpen Access
The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma
Virus Research·2015· 46 cited
118. Inhibition of Hepatitis B Virus Replication In Vivo Following Delivery of Antiviral TALENs With Recombinant Adeno-Associated Viral Vectors
Molecular Therapy·2015Open Access
483. Epigenetic Silencing of Hepatitis B cccDNA In Vitro and In Vivo Using AAV-Delivered Engineered Repressor Transcription Activator-Like Effector
Molecular Therapy·2015· 2 citedOpen Access
Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery·2014· 75 cited

Frequent Co-authors

Gang Bao(6), Patrick Arbuthnot(6), Abdullah Ely(5), Samantha Nicholson(4), Ciaran M. Lee(3), Kristie Bloom(3), Koichi Watashi(3), Tristan Scott(2), Logan Thrasher Collins(2), Wandy L. Beatty(2), Michele Alves‐Bezerra(2), Ayrea Hurley(2), William R. Lagor(2), David T. Curiel(2), Claudio Mussolino(2), Toni Cathomen(2), Sheng Tong(1), Kam W. Leong(1), Jo‐Anne de la Mare(1), Lara Contu(1)